Absorption Kinetics of Polyphenols in Angel's Plant (Angelica Keiskei)
NCT ID: NCT00721643
Last Updated: 2017-04-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
EARLY_PHASE1
10 participants
INTERVENTIONAL
2008-07-31
2010-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Bioactive Plant Foods: Effects on Functional Bioavailability and Genomic Stability
NCT00963118
Efficacy and Safety of Angelica Gigas Nakai and Allium Cepa L.Extract Mixtures on the Improvement of Blood Flow
NCT04389125
Antioxidative Effect of Plantago Asiatica L. Extract
NCT01278589
Efficacy and Safety of Unripe Bokbunja Extract on Improvement of Blood Cholesterol
NCT03649620
Absorption Profiles of Three Polyphenol Preparations With and Without Pollen Shell Covering
NCT02116816
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Healthy control, 5g dry power of angel's plant (Angelica keiskei)
angel's plant (Angelica keiskei)
Healthy control, one time dose of 5g dry power of Angelica keiskei
2
Metabolic syndrome, 5g dry powder of angel's plant (Angelica keiskei)
Angel's plant (Angelica keiskei)
Metaboic syndrome subjects, one time dose of 5g dry powder of angel's plant (Angelica keiskei)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
angel's plant (Angelica keiskei)
Healthy control, one time dose of 5g dry power of Angelica keiskei
Angel's plant (Angelica keiskei)
Metaboic syndrome subjects, one time dose of 5g dry powder of angel's plant (Angelica keiskei)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* subjects with metabolic syndrome (\>60 yr, n=5)
* Subjects who has
* high fasting plasma glucose (\>5.6 mmol/L),
* central obesity (waist-hip ratio, \>0.9 for men, \>0.85 for women)
* either high blood pressure (\>130/85 mmHg) or high triacylglycerol (\>1.7 mmol/L) will be selected to have metabolic syndrome.
* normal hematological parameters, normal serum albumin, normal liver function, and normal kidney function
* no history of smoking or alcoholism.
Exclusion Criteria
* taking cholesterol medication or hormone replacement
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tufts University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jean Mayer USDA-Human Nutrition Research Center on Aging at Tufts University
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kyung-Jin Yeum, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
Tufts Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Jean Mayer USDA-Human Nutrition Research Center on Aging at Tufts University
Boston, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BioGreen 20070301034009
Identifier Type: -
Identifier Source: secondary_id
HNRCA2580
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.